FSD Pharma Acquires Prismic Pharmaceuticals

FSD Pharma Inc. (CSE: HUGE), a Canadian-based cannabis company, has acquired Prismic Pharmaceuticals Inc. a specialty pharmaceutical company focused on novel non-addictive prescription drugs for the treatment of pain, inflammation and neurological disorder. The transaction cost approximately $17.5 million, but FSD gains Prismic’s worldwide licensing rights to a patent-protected form of palmitoylethanolamide, which can increase the effectiveness while […]